previous compound ID: 1208 next compound
InChIKey: KTGRHKOEFSJQNS-BDQAORGHSA-N
SMILES: CN(C)CCC[C@@]1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F.C(=O)(C(=O)O)O

biological descriptors:

CFTR relevance: unspecified

Category:
Influence on CFTR function unknown
Order of interaction unknown
subcellular compartment unknown

reference list:

ReferenceID: 53
"B Kus" "GW Carlile" "J Liao" "JW Hanrahan" "SD Macknight" "E Matthes" "D Rotin" "J Goepp" "R Robert" "DY Thomas"

chemical graph of compound 1208





CID is 146571
synonyms found at PubChem are:
Escitalopram oxalate, 219861-08-2, Lexapro, Cipralex, (S)-Citalopram Oxalate, Escitalopram (oxalate), Citalopram Oxalate, UNII-5U85DBW7LO, (S)-(+)Citalopram oxalate, 5U85DBW7LO, (S)-(+)-Citalopram Oxalate, (S)-1-(3-(Dimethylamino)propyl)-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile oxalate, NCGC00095903-01, Lu 26-054-0, Lexapro (TN), DSSTox_CID_26003, DSSTox_RID_81282, DSSTox_GSID_46003, C22H23FN2O5, S-(+)-1-(3-(Dimethylamino)propyl)-1-(p-fluorophenyl)-5-phthalancarbonitrile oxalate, 5-Isobenzofurancarbonitrile, 1-(3-(dimethylamino)propyl)-1-(4-fluorophenyl)-1,3-dihydro-, (1S)-, ethanedioate (1:1), S-(+)-5-Isobenzofurancarbonitrile, 1-(3-(dimethylamino)propyl)-1-(4-fluorophenyl)-1,3-dihydro-, oxalate, CAS-219861-08-2, Lu-26-054-0, Gaudium, Entact, (1S)-1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-3H-2-benzofuran-5-carbonitrile;oxalic acid, (1S)-1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-3H-isobenzofuran-5-carbonitrile; oxalic acid, (S)-1-[3-(Dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile Oxalate, AC1L3TGZ, Escitalopram oxalate [USAN], SCHEMBL35123, cc-372, MLS001401408, SPECTRUM1505216, (+)-(S)-Citalopram oxalate, MLD-55, CHEMBL1200322, DTXSID1046003, AOB4715, Escitalopram oxalate (JAN/USAN), Escitalopram oxalate [USAN:USP], KTGRHKOEFSJQNS-BDQAORGHSA-N, MolPort-003-666-613, HMS2051D11, HMS2231M16, HMS3370I17, HMS3393D11, HMS3713D16, Pharmakon1600-01505216, BCP05686, Tox21_111535, BG0433, CCG-39559, HY-14258A, NSC758934, AKOS016340275, Tox21_111535_1, AC-6770, AN-9671, CS-2054, KS-1263, NC00194, NSC-758934, NCGC00178555-02, AN-13009, CPD000469191, SAM001246668, SMR000469191, AB0012102, AX8019428, LS-183519, LU-260540, TL8001823, E0958, FT-0650410, ST24046691, D02567, Escitalopram oxalate, >=98% (HPLC), powder, J90016, Escitalopram pound Escitalopram Oxalate pound(c), 861E082, SR-01000763053, SR-01000763053-3, UNII-B5RDX2419X component KTGRHKOEFSJQNS-BDQAORGHSA-N, Escitalopram oxalate, EuropePharmacopoeia (EP) Reference Standard, Escitalopram oxalate, United States Pharmacopeia (USP) Reference Standard, Escitalopram for system suitability, EuropePharmacopoeia (EP) Reference Standard, Escitalopram Oxalate, Pharmaceutical Secondary Standard; Certified Reference Material, (+)-(S)-1-[3-(Dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-5-isobenzofurancarbonitrile oxalate, (1S)-1-[3-(Dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-5-isobenzofurancarbonitrile Ethanedioate, (1S)-1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-3H-2-benzofuran-5-carbonitrile; oxalic acid, S-(+)-1-[3-(Dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-5-isobenzofurancarbonitrile oxalate